Quintet Private Bank Europe S.A. Raises Stock Holdings in CME Group Inc. (NASDAQ:CME)

Quintet Private Bank Europe S.A. lifted its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 29.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 30,287 shares of the financial services provider's stock after purchasing an additional 6,815 shares during the quarter. Quintet Private Bank Europe S.A.'s holdings in CME Group were worth $6,683,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Capital International Investors boosted its holdings in shares of CME Group by 24.1% in the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider's stock valued at $3,403,557,000 after buying an additional 3,069,806 shares in the last quarter. PineStone Asset Management Inc. boosted its stake in CME Group by 137.6% in the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider's stock valued at $444,443,000 after acquiring an additional 1,309,097 shares in the last quarter. M&G Plc acquired a new position in CME Group in the first quarter valued at $156,631,000. Assenagon Asset Management S.A. grew its holdings in shares of CME Group by 577.9% during the second quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider's stock worth $126,872,000 after purchasing an additional 550,133 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its position in shares of CME Group by 11.3% during the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider's stock worth $1,038,676,000 after purchasing an additional 537,758 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.

Analysts Set New Price Targets

CME has been the subject of a number of research analyst reports. Oppenheimer upped their target price on CME Group from $245.00 to $258.00 and gave the company an "outperform" rating in a research report on Thursday, October 24th. Piper Sandler raised their target price on shares of CME Group from $240.00 to $250.00 and gave the stock an "overweight" rating in a research report on Monday, October 28th. Citigroup upped their price target on shares of CME Group from $250.00 to $255.00 and gave the company a "buy" rating in a research report on Thursday, October 24th. Keefe, Bruyette & Woods lifted their price objective on shares of CME Group from $212.00 to $213.00 and gave the company a "market perform" rating in a research note on Thursday, July 25th. Finally, Redburn Atlantic cut CME Group from a "buy" rating to a "neutral" rating and set a $244.00 price target for the company. in a research note on Tuesday, October 8th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $222.73.

CME Group Price Performance

Shares of NASDAQ:CME traded down $1.30 during midday trading on Monday, hitting $222.31. 721,048 shares of the stock were exchanged, compared to its average volume of 1,911,902. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.36. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The company has a 50 day moving average price of $220.69 and a 200-day moving average price of $209.49. The stock has a market cap of $80.05 billion, a P/E ratio of 23.51, a PEG ratio of 5.67 and a beta of 0.55.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.65 by $0.03. The company had revenue of $1.58 billion during the quarter, compared to analysts' expectations of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm's quarterly revenue was up 18.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.25 earnings per share. On average, research analysts forecast that CME Group Inc. will post 10.23 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were paid a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.07%. The ex-dividend date of this dividend was Monday, September 9th. CME Group's payout ratio is currently 48.37%.

Insider Buying and Selling at CME Group

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the company's stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Bryan T. Durkin sold 7,593 shares of the firm's stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares of the company's stock, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Timothy Francis Mccourt sold 1,374 shares of the company's stock in a transaction on Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the sale, the insider now owns 7,275 shares of the company's stock, valued at approximately $1,652,298. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,221 shares of company stock worth $3,351,895. 0.30% of the stock is owned by insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.